We are live on ! Find out more
SAM

Silvercrest Asset Management Portfolio holdings

AUM $13.8B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+28.39%
3 Year Est. Return
+72%
5 Year Est. Return
+95.52%
10 Year Est. Return
+377.43%
AUM
$14B
AUM Growth
+$850M
Cap. Flow
+$380M
Cap. Flow %
2.71%
Top 10 Hldgs %
12.18%
Holding
859
New
65
Increased
475
Reduced
192
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 18.17%
2 Industrials 17.33%
3 Healthcare 13.07%
4 Financials 11.52%
5 Consumer Discretionary 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLT icon
351
Commault Systems
CVLT
$4.98B
$5.37M 0.04%
74,000
-15,693
-17% -$1.02M
AIT icon
352
Applied Industrial Technologies
AIT
$12.4B
$5.37M 0.04%
+37,079
New +$4.95M
PXD
353
DELISTED
Pioneer Natural Resource Co.
PXD
$5.37M 0.04%
25,919
-48,083
-65% -$10.1M
CYRX icon
354
CryoPort
CYRX
$753M
$5.33M 0.04%
308,985
+88,748
+40% +$1.82M
FC icon
355
Franklin Covey
FC
$239M
$5.3M 0.04%
121,240
+17,336
+17% +$642K
MTD icon
356
Mettler-Toledo International
MTD
$28.1B
$5.2M 0.04%
3,961
+131
+3% +$184K
MSI icon
357
Motorola Solutions
MSI
$72.1B
$5.12M 0.04%
17,454
+4,063
+30% +$1.16M
ENTG icon
358
Entegris
ENTG
$16.3B
$5.1M 0.04%
46,011
+29,119
+172% +$2.66M
MMM icon
359
3M
MMM
$91.8B
$5.06M 0.04%
60,482
+4,704
+8% +$400K
ITCI
360
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.97M 0.04%
78,444
+11,726
+18% +$731K
NSC icon
361
Norfolk Southern
NSC
$75.4B
$4.96M 0.04%
21,865
-714
-3% -$152K
VRTX icon
362
Vertex Pharmaceuticals
VRTX
$123B
$4.93M 0.04%
14,002
+583
+4% +$196K
PCRX icon
363
Pacira BioSciences
PCRX
$1.04B
$4.92M 0.04%
122,854
+18,596
+18% +$769K
STAA icon
364
STAAR Surgical
STAA
$1.19B
$4.81M 0.03%
91,440
+29,632
+48% +$1.8M
DXCM icon
365
DexCom
DXCM
$29B
$4.8M 0.03%
37,350
+4,915
+15% +$594K
LPRO
366
Open Lending Corp
LPRO
$372M
$4.79M 0.03%
456,086
+65,392
+17% +$578K
IIIV icon
367
i3 Verticals
IIIV
$419M
$4.79M 0.03%
209,530
+29,585
+16% +$690K
LITE icon
368
Lumentum
LITE
$46.9B
$4.73M 0.03%
83,297
+12,120
+17% +$606K
TNDM icon
369
Tandem Diabetes Care
TNDM
$1.27B
$4.7M 0.03%
191,699
+28,095
+17% +$904K
BTI icon
370
British American Tobacco
BTI
$136B
$4.59M 0.03%
138,210
+28,498
+26% +$974K
SOVO
371
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$4.57M 0.03%
+233,773
New +$4.22M
SBUX icon
372
Starbucks
SBUX
$119B
$4.56M 0.03%
45,983
+1,004
+2% +$104K
CCEP icon
373
Coca-Cola Europacific Partners
CCEP
$49.1B
$4.52M 0.03%
70,175
-28,712
-29% -$1.82M
CL icon
374
Colgate-Palmolive
CL
$74.8B
$4.47M 0.03%
57,984
+3,502
+6% +$271K
IEUR icon
375
iShares Core MSCI Europe ETF
IEUR
$8.8B
$4.46M 0.03%
84,748

Similar funds

Silvercrest Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Silvercrest Asset Management held 859 positions worth $14B, up 6.5% from $13.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Silvercrest Asset Management's Q2 2023 filing shows 65 new, 475 increased, 192 reduced and 36 closed positions. Its largest new stake was RenaissanceRe: 205,221 shares worth $38.3M. The largest sale was Syneos Health, Inc. Class A Common Stock, an estimated $58.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Silvercrest Asset Management's largest Q2 2023 buy was RenaissanceRe: 205,221 shares worth $38.3M.
  • Silvercrest Asset Management added most to Dentsply Sirona in Q2 2023, an estimated $59.1M increase.
  • Silvercrest Asset Management's biggest Q2 2023 reduction was Syneos Health, Inc. Class A Common Stock, cutting an estimated $58.2M.
  • Silvercrest Asset Management fully exited MillerKnoll in Q2 2023, selling an estimated $33.2M.
  • Silvercrest Asset Management's ten largest holdings make up 12% of its $14B portfolio in Q2 2023.
  • Silvercrest Asset Management opened 65 new positions and closed 36 in Q2 2023.
  • Silvercrest Asset Management's portfolio value rose 6.5% quarter-over-quarter to $14B.

Based on Silvercrest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.